138 related articles for article (PubMed ID: 31455252)
1. Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer.
Islam KM; Anggondowati T; Deviany PE; Ryan JE; Fetrick A; Bagenda D; Copur MS; Tolentino A; Vaziri I; McKean HA; Dunder S; Gray JE; Huang C; Ganti AK
BMC Cancer; 2019 Aug; 19(1):835. PubMed ID: 31455252
[TBL] [Abstract][Full Text] [Related]
2. Patient-Defined Treatment Success: Perspectives of Patients With Advanced-Stage Lung Cancer.
Islam KM; Deviany PE; Anggondowati T; Ryan JE; Fetrick A; Bagenda D; Copur MS; Tolentino A; Vaziri I; McKean HA; Dunder S; Gray JE; Huang CMD; Ganti AK
J Oncol Pract; 2019 Sep; 15(9):e758-e768. PubMed ID: 31322990
[TBL] [Abstract][Full Text] [Related]
3. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
Mandrekar SJ; Northfelt DW; Schild SE; Foster NR; Bot B; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Adjei AA; Jett JR
J Thorac Oncol; 2006 Jul; 1(6):556-63. PubMed ID: 17409917
[TBL] [Abstract][Full Text] [Related]
4. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
[TBL] [Abstract][Full Text] [Related]
5. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
6. Preference weights for chemotherapy side effects from the perspective of women with breast cancer.
Kuchuk I; Bouganim N; Beusterien K; Grinspan J; Vandermeer L; Gertler S; Dent SF; Song X; Segal R; Mazzarello S; Crawley F; Dranitsaris G; Clemons M
Breast Cancer Res Treat; 2013 Nov; 142(1):101-7. PubMed ID: 24129976
[TBL] [Abstract][Full Text] [Related]
7. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
8. Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy.
Lee JS; Lee KH; Cho EK; Kim DW; Kim SW; Kim JH; Cho BC; Kang JH; Han JY; Min YJ; Park K
Lung Cancer; 2018 Aug; 122():234-242. PubMed ID: 30032838
[TBL] [Abstract][Full Text] [Related]
9. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
[TBL] [Abstract][Full Text] [Related]
10. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
[TBL] [Abstract][Full Text] [Related]
11. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
[TBL] [Abstract][Full Text] [Related]
13. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
[TBL] [Abstract][Full Text] [Related]
14. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
[TBL] [Abstract][Full Text] [Related]
15. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
Pearce A; Haas M; Viney R; Pearson SA; Haywood P; Brown C; Ward R
PLoS One; 2017; 12(10):e0184360. PubMed ID: 29016607
[TBL] [Abstract][Full Text] [Related]
16. Does granulocyte colony-stimulating factor affect survival in patients with advanced non-small cell lung cancer?
Kasymjanova G; Kreisman H; Correa JA; Dajczman E; Small D
J Thorac Oncol; 2006 Jul; 1(6):564-70. PubMed ID: 17409918
[TBL] [Abstract][Full Text] [Related]
17. High BMI and low HDL-C predict the chemotherapy-related hepatic dysfunction in Chinese advanced NSCLC patients.
Lv Y; Ding XS; Li Y; An X; Miao LY
Cancer Biomark; 2016; 16(1):89-97. PubMed ID: 26835709
[TBL] [Abstract][Full Text] [Related]
18. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
[TBL] [Abstract][Full Text] [Related]
19. Screening for patients with non-small cell lung cancer who could survive long term chemotherapy.
Wu XY; Huang XE
Asian Pac J Cancer Prev; 2015; 16(2):647-52. PubMed ID: 25684501
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
